Integrating mass spectrometry-based plasma (or serum) protein N-glycan profiling into the clinical practice?
- 1 September 2019
- journal article
- editorial
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 7 (S6) , S225
Abstract
Integrating mass spectrometry-based plasma (or serum) protein N-glycan profiling into the clinical practice?Keywords
This publication has 24 references indexed in Scilit:
- Increased Clinical Sensitivity and Specificity of Plasma Protein N-Glycan Profiling for Diagnosing Congenital Disorders of Glycosylation by Use of Flow Injection–Electrospray Ionization–Quadrupole Time-of-Flight Mass SpectrometryClinical Chemistry, 2019
- A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathyNeurology, 2019
- Complementarity of electrophoretic, mass spectrometric, and gene sequencing techniques for the diagnosis and characterization of congenital disorders of glycosylationElectrophoresis, 2018
- Direct comparison of derivatization strategies for LC-MS/MS analysis ofN-glycansThe Analyst, 2017
- Human Plasma N-glycosylation as Analyzed by Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Ion Cyclotron Resonance-MS Associates with Markers of Inflammation and Metabolic HealthMolecular & Cellular Proteomics, 2017
- Human plasma protein N-glycosylationGlycoconjugate Journal, 2015
- Transferrin variants: Pitfalls in the diagnostics of Congenital disorders of glycosylationClinical Biochemistry, 2015
- Plasma N-Glycan Profiling by Mass Spectrometry for Congenital Disorders of Glycosylation Type IIClinical Chemistry, 2011
- The N-Glycome of Human PlasmaJournal of Proteome Research, 2010
- The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-IbBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009